{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:35:00Z","timestamp":1777883700681,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmcl.2026.130615","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:47:08Z","timestamp":1772610428000},"page":"130615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ferrocenyl substitution turns valproate into a glutamate decarboxylase inhibitor"],"prefix":"10.1016","volume":"136","author":[{"given":"Danijela N.","family":"Nikoli\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija S.","family":"Gen\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Arsi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan S.","family":"Ne\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola M.","family":"Stojanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko Z.","family":"Mladenovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niko S.","family":"Radulovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130615_bb0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.bmcl.2026.130615_bb0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.bmcl.2026.130615_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cnr.2004.09.013","article-title":"Valproic acid: how it works. Or not","volume":"4","author":"Lagace","year":"2004","journal-title":"Clin Neurosci Res"},{"key":"10.1016\/j.bmcl.2026.130615_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00019052-200304000-00014","article-title":"New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?","volume":"16","author":"Isoherranen","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.bmcl.2026.130615_bb0025","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/cbic.202000124","article-title":"Effect of regiochemistry and methylation on the anticancer activity of a ferrocene-containing organometallic nucleoside analogue","volume":"21","author":"Ismail","year":"2020","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmcl.2026.130615_bb0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/inorganics10120226","article-title":"Modern trends in bio-organometallic ferrocene chemistry","volume":"10","author":"Snegur","year":"2022","journal-title":"Inorganics"},{"key":"10.1016\/j.bmcl.2026.130615_bb0035","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0960-894X(00)00120-7","article-title":"Synthesis and antifungal activity of a ferrocene\u2013fluconazole analogue","volume":"10","author":"Biot","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130615_bb0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11030-014-9511-0","article-title":"Synthesis, characterization, and antimicrobial evaluation of a small library of ferrocene-containing acetoacetates and phenyl analogs: the discovery of a potent anticandidal agent","volume":"18","author":"Radulovi\u0107","year":"2014","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmcl.2026.130615_bb0045","series-title":"Synthesis of Oxidative Metabolites of di(2-Ethylhexyl)Phthalate","author":"McDaniel","year":"2017"},{"key":"10.1016\/j.bmcl.2026.130615_bb0050","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1016\/S0040-4020(01)85127-9","article-title":"Undecaprenyl diphosphate synthase reaction with artificial substrate homologues\u2014novel behavior in the termination of prenyl chain elongation","volume":"45","author":"Ohnuma","year":"1989","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2026.130615_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2021.112732","article-title":"Long-chain syn-1-phenylalkane-1,3-diyl diacetates, related phenylalkane derivatives, and sec-alcohols, all possessing dominantly iso-branched chain termini, and 2\/3-methyl-branched fatty acids from Primula veris L. (Primulaceae) wax","volume":"186","author":"Radulovi\u0107","year":"2021","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmcl.2026.130615_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/macp.200900432","article-title":"Polyethylene prodrugs using precisely placed pharmaceutical agents","volume":"211","author":"Leonard","year":"2010","journal-title":"Macromol Chem Phys"},{"key":"10.1016\/j.bmcl.2026.130615_bb0065","series-title":"Organic Chemistry","author":"Clayden","year":"2012"},{"key":"10.1016\/j.bmcl.2026.130615_bb0070","series-title":"Transition States of Biochemical Processes","first-page":"467","article-title":"Decarboxylations of \u03b2-keto acids and related compounds","author":"Pollack","year":"1978"},{"key":"10.1016\/j.bmcl.2026.130615_bb0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1023\/A:1021664221582","article-title":"Thermal stability of ferrocene derivatives and ferrocene-containing polyamides","volume":"70","author":"de Souza","year":"2002","journal-title":"J Therm Anal Calorim"},{"key":"10.1016\/j.bmcl.2026.130615_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejmech.2014.05.062","article-title":"Discovery of anxiolytic 2-ferrocenyl-1,3-thiazolidin-4-ones exerting GABA receptor interaction via the benzodiazepine-binding site","volume":"83","author":"Pejovi\u0107","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130615_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105433","article-title":"An HPLC-based assay for improved measurement of glutamate decarboxylase inhibition\/activation","volume":"161","author":"Gen\u010di\u0107","year":"2022","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bmcl.2026.130615_bb0090","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/0006-2952(81)90323-3","article-title":"Valproate induced changes in GABA metabolism at the subcellular level","volume":"30","author":"L\u00f6scher","year":"1981","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130615_bb0095","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/S0031-9422(00)82458-9","article-title":"Effect of cyclic analogues of valproic acid on glutamic acid decarboxylase activity as determined by different methods","volume":"26","author":"Sethi","year":"1987","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmcl.2026.130615_bb0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0306-3623(95)02092-6","article-title":"Valproic acid differs in its in vitro effect on glutamic acid decarboxylase activity in neonatal and adult rat brain","volume":"27","author":"Wikinski","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130615_bb0105","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.3390\/ijms26072865","article-title":"Inhibitory potential of boscalid and abamectin towards acetylcholinesterase and butyrylcholinesterase: computational and in vitro studies","volume":"26","author":"Arsi\u0107","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2026.130615_bb0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nsmb1228","article-title":"GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop","volume":"14","author":"Fenalti","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmcl.2026.130615_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13321-020-00440-9","article-title":"EDock: blind protein\u2013ligand docking by replica-exchange Monte Carlo simulation","volume":"12","author":"Zhang","year":"2020","journal-title":"J Cheminform"},{"key":"10.1016\/j.bmcl.2026.130615_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1016357811882","article-title":"Further development and validation of empirical scoring functions for structure-based binding affinity prediction","volume":"16","author":"Wang","year":"2002","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmcl.2026.130615_bb0125","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0006-3495(03)74551-2","article-title":"Touchstone II: a new approach to ab initio protein structure prediction","volume":"85","author":"Zhang","year":"2003","journal-title":"Biophys J"},{"key":"10.1016\/j.bmcl.2026.130615_bb0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2016.04.036","article-title":"Neuroinformatics analyses reveal GABAt and SSADH as major proteins involved in anticonvulsant activity of valproic acid","volume":"81","author":"Piplani","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2026.130615_bb0135","doi-asserted-by":"crossref","first-page":"37200","DOI":"10.1074\/jbc.274.52.37200","article-title":"The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65","volume":"274","author":"Kanaani","year":"1999","journal-title":"J Biol Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:55:05Z","timestamp":1777600505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2600082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S0960894X2600082X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130615","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferrocenyl substitution turns valproate into a glutamate decarboxylase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130615"}}